ClinicalTrials.gov
public full text
Public Domain
Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
This study uses a computerized method of musical instrument digital interface (MIDI) quantification of performance before and after treatment with botulinum toxin type B (Myobloc ®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used medically to relax unwanted muscle spasms and movements. The aim of the study is to determine the feasibility of quantifying change in performance following treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Myobloc Atrophy Study#872602
- Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm#873542
- Repetitive Transcranial Magnetic Stimulation in Essential Tremors Patients#878496
- Music as Autistic Sense-making: Toward an Enactive Framework of Neuro-affirming Music Therapy#97902
- Motor Control in Chronic Fatigue Syndrome and Fibromyalgia#807518
Record · ID 890454
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive